Frank Douglas

Frank Lennox Douglas was the founder of MIT Center for Biomedical Innovation, founded in 2005, where the title held was Executive Director.
Dr. Douglas is the founder of Safe Haven Dialogues LLC, founded in 2020, holding the title of Chief Executive Officer.
Current jobs include Chairman at Alantos Pharmaceuticals Holding, Inc., Director at Battelle Corp.
since 2012, Director at XaTek, Inc. since 2018, and Director at EOM Pharmaceuticals Holdings, Inc. since 2021.
Former jobs include Chairman at Solace Pharmaceuticals, Inc. and Alantos Pharmaceuticals AG; Director at Gene Logic, Inc. from 2004 to 2008; Director at Battelle Memorial Institute from 2013 to 2018; Director at NitroMed, Inc. from 2005 to 2009; Director at Archemix Corp.; Independent Director at ImmunoCellular Therapeutics Ltd.; Director at The Multiple Myeloma Research Foundation, Inc.; Director at Multiple Myeloma Research Consortium; Director at Ore Pharmaceuticals, Inc.; Director at Enlight Biosciences LLC; Director at TheVax Genetics Vaccine Co., Ltd. from 2015 to 2017; Director at Visgenx, Inc.; Chief Scientific Officer & Executive VP at Aventis SA from 1997 to 2004; Executive Vice President at Aventis Pharmaceuticals, Inc.; Senior Vice President at Ciba-Geigy AG; Member-Supervisory Board at ALTANA Pharma AG; Professor at Massachusetts Institute of Technology from 2005 to 2007; Senior Partner at PureTech Health LLC; Trustee at Ewing Marion Kauffman Foundation; EVP, Head-Global Research & Development at Hoechst Marion Roussel, Inc. from 1995 to 1999.
Education includes undergraduate degree from Lehigh University and doctorate from Cornell University.